Stay updated on Talquetamab Dose Escalation in Myeloma Clinical Trial
Sign up to get notified when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.

Latest updates to the Talquetamab Dose Escalation in Myeloma Clinical Trial page
- Check5 days agoChange DetectedThe latest version adds two new sections to the history view, Study Status and Study Identification, signaling updates to the trial's current status and identifiers. An entry on 2026-07-02 includes the value '85', and a prior deletion on 2026-06-05 indicates a removal from the history.SummaryDifference0.2%

- Check12 days agoChange DetectedThe page history shows a revision change from v3.6.2 to v3.6.3. This indicates a minor internal update to the page version rather than changes to the study details or its presentation.SummaryDifference0.0%

- Check19 days agoChange DetectedRevision: v3.6.2 was added and Revision: v3.6.0 was removed from the page history. This reflects a minor platform update rather than changes to the study record content.SummaryDifference0.0%

- Check34 days agoChange DetectedRecruitment for the study is no longer open to new participants. The record has been updated to revision v3.6.0, and the previous revision v3.5.5 has been removed.SummaryDifference0.2%

- Check41 days agoChange DetectedThe page's revision label updated from v3.5.4 to v3.5.5, signaling a new build release. This update is a minor internal version change and does not modify study content or user-facing features.SummaryDifference0.0%

- Check62 days agoChange DetectedA new revision entry (v3.5.4) dated 2026-05-08 with an added 'Study Status' section appears in the history, replacing the prior revision entry (v3.5.3) dated 2026-04-13.SummaryDifference0.2%

Stay in the know with updates to Talquetamab Dose Escalation in Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Talquetamab Dose Escalation in Myeloma Clinical Trial page.